References

  1. Loken MR, Herzenberg LA. Analysis of cell populations with a fluorescence-activated cell sorter. Ann NY Acad of Sci 1975; 254: 163.
  2. Loken MR, Stout RD, Herzenberg LA. Lymphoid cell analysis and sorting.  . In: Mclamed MR, Mullaney PF, Mendelsohn ML (eds). Flow Cytometry and Sorting. John Wiley and Sons: New York, 1979, pp 505.
  3. Loken MR, Stall AM. Flow cytometry as an analytical and preparative tool in immunology. J Immunol Methods 1982; 50(3): R85.
  4. Loken MR, Parks DR, Herzenberg LA. Two-color immunofluorescence using a fluorescence-activated cell sorter. J Histochem Cytochem 1977 Jul; 25(7): 899.
  5. Loken MR, Lanier LL. Three-color immunofluorescence analysis of Leu antigens on human peripheral blood using two lasers on a fluorescence-activated cell sorter. Cytometry 1984 Mar; 5(2): 151.
  6. Loken M, Parks DR, Hardy RR, inventors; Method and apparatus for distinguishing multiple subpopulations of cells in a sample. European Patent 0121262B1.
  7. Loken MR, Sweet RG, Herzenberg LA. Cell discrimination by multiangle light scattering. J Histochem Cytochem 1976 Jan; 24(1): 284.
  8. Horan PK, Loken MR. A practical guide for the use of flow systems in flow cytometry. In: Van Dilla MA (ed).Instrumentation and Data Analysis. Academic press: San Diego, 1985, pp 260.
  9. Terstappen LW, Mickaels RA, Dost R, Loken MR. Increased light scattering resolution facilitates multidimensional flow cytometric analysis. Cytometry 1990; 11(4): 506.
  10. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987 Jan; 69(1): 255.
  11. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987 Nov; 70(5): 1316.
  12. Terstappen LW, Safford M, Loken MR. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia 1990 Sep; 4(9): 657.
  13. Shah VO, Civin CI, Loken MR. Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. J Immunol 1988 Mar 15;140(6): 1861.
  14. Terstappen LW, Hollander Z, Meiners H, Loken MR. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol 1990 Aug; 48(2): 138.
  15. Terstappen LW, Johnsen S, Segers-Nolten IM, Loken MR. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood 1990 Nov 1; 76(9): 1739.
  16. Loken MR, Civin CI, Bigbee WL, Langlois RG, Jensen RH. Coordinate glycosylation and cell surface expression of glycophorin A during normal human erythropoiesis. Blood 1987 Dec; 70(6): 1959.
  17. Loken MR, Shah VO, Hollander Z, Civin CI. Flow cytometric analysis of normal B lymphoid development.Pathol Immunopathol Res 1988; 7(5): 357.
  18. Terstappen LWMM, Segers-Nolten, I., Safford, M., Shah, V.O., Loken, M.R. . Monomyeloid cell differentiation in normal bone marrow assessed by multidimensional flow cytometry. In: Burger G, Oberholzer, M., Vooijs, G.P. (ed). Advances in Analytical Cellular Pathology. Excerpta Medica: Amsterdam, 1990, pp 211.
  19. Civin CI, Banquerigo ML, Strauss LC, Loken MR. Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol 1987 Jan;15(1): 10.
  20. Civin CI, Strauss LC, Fackler MJ, Trischmann TM, Wiley JM, Loken MR. Positive stem cell selection:  Basic science.  . In: Liss AR, Gee A, Worthing-White D (eds). Bone Marrow Purging and Processing. Alan R. Liss: New York, 1990, pp 387.
  21. Loken MR, Civin CI. Laboratory Assessment of Lymphohematopoietic Progenitor and Stem Cells. In: Smith DM, Sacher RA (eds). Peripheral Blood Stem Cells. Amer. Assoc. Blood Banks: Bethesda, 1993, pp 19.
  22. Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 1991 Mar 15;77(6): 1218.
  23. Terstappen LWMM, Loken MR, Huang S, Olweus J, Lund-Johansen F, inventors; Phenotypic characterization of the hematopoietic stem cell. US Patent #5,840,580.
  24. Loken MR, Chu SC, Fritschle W, Kalnoski M, Wells DA. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses. Cytometry B Clin Cytom 2008 Jun 11; 76B(1): 27.
  25. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci 1993 Mar 20; 677: 265.
  26. Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990; 11(4): 453.
  27. Loken M.R., Civin, C.I., Shah, V.O., inventors; Method to determine the composition of bone marrow samples. US Patent # 5,137,809.
  28. Recktenwald DJ, R.S. K, Chen CH, Loken MR, inventors; Method and materials for calibrating flow cytometers and other analysis instruments.US Patent #4,704,891.
  29. Hurwitz CA, Loken MR, Graham ML, Karp JE, Borowitz MJ, Pullen DJ, et al. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 1988 Jul; 72(1): 299.
  30. Terstappen LWMM, Loken MR. Multi-dimensional flow cytometric characterization of myeloid maturation in normal bone marrow and acute myeloid leukemia.  i. In: Burger G, Oberholzer M, Vooijs GP (eds).Advances in Analytical Cellular Pathology. Excerpta Medica: Amsterdam, 1990, pp 209.
  31. Terstappen LW, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol 1990 Jul; 2(4): 229.
  32. Terstappen LW, Konemann S, Safford M, Loken MR, Zurlutter K, Buchner T, et al. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties. Leukemia1991 Apr; 5(4): 315.
  33. Terstappen LW, Safford M, Konemann S, Loken MR, Zurlutter K, Buchner T, et al. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1992 Jan; 6(1): 70.
  34. Sievers EL, Lange BJ, Buckley JD, Smith FO, Wells DA, Daigneault-Creech CA, et al. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst 1996 Oct 16; 88(20): 1483.
  35. Sievers EL, Loken MR. Detection of minimal residual disease in acute myelogenous leukemia. J Pediatr Hematol Oncol 1995 May; 17(2): 123.
  36. Wells DA, Sale GE, Shulman HM, Myerson D, Bryant EM, Gooley T, et al. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol 1998 Jul; 110(1): 84.
  37. Shulman HM, Wells D, Gooley T, Myerson D, Bryant E, Loken MR. The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry.Am J Clin Pathol 1999 Oct; 112(4): 513.
  38. Sievers EL, Lange BJ, Alonzo TA, Gerbing RB, Bernstein ID, Smith FO, et al. Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children’s Cancer Group study of 252 patients with acute myeloid leukemia. Blood 2003 May 1; 101(9): 3398.
  39. Bradfield SM, Radich JP, Loken MR. Graft-versus-leukemia effect in acute lymphoblastic leukemia: the importance of tumor burden and early detection. Leukemia 2004 Jun; 18(6): 1156.
  40. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003 Jul 1; 102(1): 394.
  41. Scott BL, Wells DA, Loken MR, Myerson D, Leisenring WM, Deeg HJ. Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome. Blood 2008 Oct 1; 112(7): 2681.
  42. Loken MR, Wells DA. The role of flow cytometry in myelodysplastic syndromes. J Natl Compr Canc Netw2008 Oct; 6(9): 935.
  43. Loken MR, van de Loosdrecht A, Ogata K, Orfao A, Wells DA. Flow cytometry in myelodysplastic syndromes: report from a working conference. Leuk Res 2008 Jan; 32(1): 5.
  44. van de Loosdrecht AA, Alhan C, Bene MC, Della Porta MG, Drager AM, Feuillard J, et al. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 2009 Aug; 94(8): 1124.
  45. Wells D LM. Diagnostic and Prognostic Utility of Flow Cytometry in MDS- 2nd ed. In: Steensma DP (ed).Myelodysplastic Syndromes Pathobiology and Clinical Management, 2nd edn. Informal Healthcare USA, Inc.: New York, 2009, pp 247.
  46. Zehentner BK, Fritschle W, Stelzer T, Ghirardelli KM, Hunter K, Wentzel C, et al. Minimal disease detection and confirmation in hematologic malignancies: combining cell sorting with clonality profiling. Clin Chem2006 Mar; 52(3): 430.
  47. Sala-Torra O, Hanna C, Loken MR, Flowers ME, Maris M, Ladne PA, et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant2006 May; 12(5): 511.
  48. Zehentner BK, Loken MR, Wells DA. JAK2V617F mutation can occur exclusively in the erythroid lineage and be absent in granulocytes and progenitor cells in classic myeloproliferative disorders. Am J Hematol2006 Oct; 81(10): 806.
  49. Loken MR. Multidimensional data analysis in immunophenotyping. Curr Protoc Cytom 2001 May; Chapter 10: Unit 10 4.

This is a unique website which will require a more modern browser to work!

Please upgrade today!